BIOMAT Database Logo BIOMAT Database Logo

Pretransplant flow cytometry crossmatch in first cadaveric kidney transplants. 1995

L Mascaretti, and V Sioli, and G Puglisi, and G Rossini, and D Trezzi, and C Scarpino, and M Scalamogna, and G Sirchia
Centro Trasfusionale e di Immunologia dei Trapianti, Ospedale Maggiore Policlinico, Milan, Italy.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell

Related Publications

L Mascaretti, and V Sioli, and G Puglisi, and G Rossini, and D Trezzi, and C Scarpino, and M Scalamogna, and G Sirchia
Improved cadaveric kidney graft survival with initiation of antilymphocyte globulin pretransplant in patients with a positive flow cytometry crossmatch.
June 1996, Transplantation proceedings,
L Mascaretti, and V Sioli, and G Puglisi, and G Rossini, and D Trezzi, and C Scarpino, and M Scalamogna, and G Sirchia
Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive.
April 2001, Transplantation,
L Mascaretti, and V Sioli, and G Puglisi, and G Rossini, and D Trezzi, and C Scarpino, and M Scalamogna, and G Sirchia
The flow cytometry crossmatch in kidney transplantation.
January 1987, Clinical transplants,
L Mascaretti, and V Sioli, and G Puglisi, and G Rossini, and D Trezzi, and C Scarpino, and M Scalamogna, and G Sirchia
Comparison of complement-dependent cytotoxic and flow-cytometry crossmatch results before cadaveric kidney transplantation.
April 2013, Transplantation proceedings,
L Mascaretti, and V Sioli, and G Puglisi, and G Rossini, and D Trezzi, and C Scarpino, and M Scalamogna, and G Sirchia
Flow cytometry crossmatch and kidney graft outcome.
January 1999, Transplantation proceedings,
L Mascaretti, and V Sioli, and G Puglisi, and G Rossini, and D Trezzi, and C Scarpino, and M Scalamogna, and G Sirchia
The flow cytometry crossmatch in second kidney grafts.
December 1996, Transplantation,
L Mascaretti, and V Sioli, and G Puglisi, and G Rossini, and D Trezzi, and C Scarpino, and M Scalamogna, and G Sirchia
Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?
April 2008, Transplantation,
L Mascaretti, and V Sioli, and G Puglisi, and G Rossini, and D Trezzi, and C Scarpino, and M Scalamogna, and G Sirchia
The lymphocyte crossmatch by flow cytometry for kidney transplantation.
January 2012, Methods in molecular biology (Clifton, N.J.),
L Mascaretti, and V Sioli, and G Puglisi, and G Rossini, and D Trezzi, and C Scarpino, and M Scalamogna, and G Sirchia
Outcomes after flow cytometry crossmatch-positive lung transplants managed with perioperative desensitization.
November 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
L Mascaretti, and V Sioli, and G Puglisi, and G Rossini, and D Trezzi, and C Scarpino, and M Scalamogna, and G Sirchia
The utility of cytolytic flow cytometry crossmatch before kidney transplantation.
October 2021, Transplant immunology,
Copied contents to your clipboard!